Critical Comparison: Astrana Health (ASTH) vs. The Competition

Astrana Health (NASDAQ:ASTH) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it compare to its rivals? We will compare Astrana Health to related businesses based on the strength of its institutional ownership, risk, earnings, dividends, analyst recommendations, profitability and valuation.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Astrana Health and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0	2	8	0	2.80
Astrana Health Competitors	1849	7706	13267	815	2.55

Astrana Health presently has a consensus target price of $49.88, indicating a potential upside of 35.79%. As a group, “Healthcare Providers & Services” companies have a potential upside of 15.95%. Given Astrana Health’s stronger consensus rating and higher possible upside, equities research analysts plainly believe Astrana Health is more favorable than its rivals.

Volatility and Risk

Astrana Health has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500. Comparatively, Astrana Health’s rivals have a beta of 0.98, meaning that their average share price is 2% less volatile than the S&P 500.

Valuation & Earnings

This table compares Astrana Health and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Astrana Health	$3.18 billion	$22.49 million	44.79
Astrana Health Competitors	$19.13 billion	$288.48 million	7.41

Astrana Health’s rivals have higher revenue and earnings than Astrana Health. Astrana Health is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Profitability

This table compares Astrana Health and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Astrana Health	1.05%	10.30%	3.67%
Astrana Health Competitors	-7.80%	-141.18%	-1.53%

Institutional & Insider Ownership

52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 56.8% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 20.3% of Astrana Health shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Astrana Health beats its rivals on 9 of the 13 factors compared.

Astrana Health Company Profile

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.